Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Acquisition
The Board of Directors of Rossari Biotech Limited at its meeting held on July 30, 2021 has resolved to make a strategic investment by acquiring and/or subscribing to equity shares equivalent to 50.10% of the issued and paid-up share capital of Romakk Chemicals Private Limited Rossari Biotech Ltd - 543213 - Statement Of Deviation Or Variation For The Quarter Ended June 30, 2021
Rossari Biotech Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 for the quarter ended June 30, 2021 Rossari Biotech Ltd - 543213 - Book Closure
Rossari Biotech Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 11-Sep-2021 to 17-Sep-2021 for the purpose of Dividend. Rossari Biotech Ltd - 543213 - Board Meeting Outcome for Outcome Of Board Meeting Held On July 30, 2021
Inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2021 of the Financial Year 2021-22. Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Revision in Timing of Earnings Conference Call for investors and analysts for Q1 FY21-22. Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call for investors and analysts on Monday, August 02, 2021 Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation of Transcript of the Conference Call held on July 19, 2021 Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Approval Of Quarterly Un-Audited Financial Results For The Quarter Ended June 30, 2021
Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2021 ,inter alia, to consider and approve Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2021.
Rossari to acquire Tristar Intermediates
Rossari Biotech, a speciality chemicals manufacturer, will be acquiring 100% equity of Tristar Intermediates. Of this, 76% equity will be acquired on closing the transaction, and the balance 24% over the next 3 years, the speciality chemicals company said.
Rossari Biotech: Calibrated inorganic strategy opens up opportunities
Rossari's MA strategy is apparently focussed on encompassing complementary technology, talent, products and client base